NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma
Clinical trial NCT01521533 · COMPLETED
Trial details
- NCT number
- NCT01521533
- Sponsor
- TME Pharma AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2014-09-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.